In the early 1990s, Boon and colleagues successfully cloned the first tumor antigen, MAGEA1, using T-cell-based approach2, and MAGEA1 could have elicited a spontaneous cytotoxic T lymphocyte (CTL) response in the autologous melanoma patients3. The gene discussed is MAGEA1; the disease is neoplasm.